However, in the case‐matched cohort, carboplatin dose was significantly associated with grade 3/4 anaemia (odds ratio, 2.68; 95% confidence interval, 1.18–6.10; p = 0.019), in addition to low baseline Hb level and a rapid drop in Hb level after the first cycle. This evidence concerns the gene GSTM1 and anemia.